4//SEC Filing
Chelsea Therapeutics International, Ltd. 4
Accession 0001144204-14-004039
CIK 0001333763operating
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 8:07 PM ET
Size
17.5 KB
Accession
0001144204-14-004039
Insider Transaction Report
Form 4
Rueckert William Dodge
Director
Transactions
- Award
Stock Option (Right to Buy)
2014-01-22+35,000→ 35,000 totalExercise: $4.65Exp: 2024-01-22→ Common Stock (35,000 underlying)
Holdings
- 5,000(indirect: By Children)
Common Stock
- 5,000(indirect: By Children)
Common Stock
- 35,000
Common Stock
- 35,000
Stock Option (Right to Buy)
Exercise: $0.96Exp: 2023-01-07→ Common Stock (35,000 underlying) - 35,000
Stock Option (Right to Buy)
Exercise: $1.15Exp: 2022-07-23→ Common Stock (35,000 underlying) - 5,000(indirect: By Children)
Common Stock
- 30,000
Stock Option (Right to Buy)
Exercise: $4.54Exp: 2022-01-25→ Common Stock (30,000 underlying) - 50,000
Stock Option (Right to Buy)
Exercise: $1.77Exp: 2014-12-31→ Common Stock (50,000 underlying) - 30,000
Stock Option (Right to Buy)
Exercise: $2.96Exp: 2020-01-19→ Common Stock (30,000 underlying) - 35,000
Stock Option (Right to Buy)
Exercise: $5.25Exp: 2019-07-23→ Common Stock (35,000 underlying) - 30,000
Stock Option (Right to Buy)
Exercise: $7.72Exp: 2021-01-11→ Common Stock (30,000 underlying)
Footnotes (9)
- [F1]The shares are held in accounts for Mr. Rueckert's children for which he serves as custodian.
- [F2]Option vests in four equal annual installments beginning on January 22, 2015.
- [F3]Option vests upon a change in control of the Company.
- [F4]Option vests in four equal annual installments beginning on January 7, 2014.
- [F5]Option vests in four equal annual installments beginning on July 23, 2013.
- [F6]Option vests in four equal annual installments beginning on January 25, 2013.
- [F7]Option vests in four equal annual installments beginning on January 11, 2012.
- [F8]Option vested in four equal annual installments beginning on January 19, 2011.
- [F9]Option vested in four equal annual installments beginning on July 23, 2010.
Documents
Issuer
Chelsea Therapeutics International, Ltd.
CIK 0001333763
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001333763
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 8:07 PM ET
- Size
- 17.5 KB